Media Release 31 July 2015
The Abortion Supervisory Committee [ASC] has decided to withhold information from women that could save the life of their unborn child. The drug Utrogestan, if taken within two days of taking Mifepristone RU 486 for a medical abortion and prior to taking the prostaglandin Misoprostol, has a 59 per cent chance of saving the life of the unborn child.
Right to Life first made a submission to the ASC in December 2014, requesting that this important information be given to all women seeking a medical abortion. The ASC responded advising that the drug Progesterone was not available in New Zealand. Right to Life responded, advising that Pharmac’s web site stated that the drug was freely available in New Zealand under the name Utrogestan. The ASC responded stating that it was not available to prevent a medical abortion. Right to Life responded that further research revealed that it was available on prescription and was standard practice to use this drug for preventing a miscarriage and therefore could be used to reverse a medical abortion..
The Committee replied on 30 July; “The Abortion Supervisory Committee (ASC) is confident in the robust pathway that is in place when women are seeking an abortion. The ASC will not be taking any action regarding the use of Utrogestan to reverse abortions.”